Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 13, 2022

SELL
$40.23 - $47.74 $211,167 - $250,587
-5,249 Closed
0 $0
Q4 2021

Jan 10, 2022

SELL
$38.88 - $45.31 $583 - $679
-15 Reduced 0.28%
5,249 $231,000
Q3 2021

Oct 13, 2021

SELL
$38.79 - $43.16 $32,273 - $35,909
-832 Reduced 13.65%
5,264 $201,000
Q2 2021

Jul 14, 2021

BUY
$36.52 - $41.46 $7,742 - $8,789
212 Added 3.6%
6,096 $243,000
Q1 2021

Apr 27, 2021

SELL
$34.27 - $40.01 $4,352 - $5,081
-127 Reduced 2.11%
5,884 $210,000
Q4 2020

Jan 21, 2021

BUY
$34.07 - $39.94 $4,463 - $5,232
131 Added 2.23%
6,011 $221,000
Q3 2020

Oct 29, 2020

SELL
$38.11 - $42.99 $4,001 - $4,513
-105 Reduced 1.75%
5,880 $221,000
Q2 2020

Jul 20, 2020

BUY
$37.87 - $43.58 $9,808 - $11,287
259 Added 4.52%
5,985 $244,000
Q1 2020

Apr 13, 2020

SELL
$32.47 - $48.83 $20,943 - $31,495
-645 Reduced 10.12%
5,726 $217,000
Q4 2019

Jan 21, 2020

BUY
$42.0 - $48.25 $6,468 - $7,430
154 Added 2.48%
6,371 $299,000
Q3 2019

Oct 24, 2019

BUY
$40.46 - $43.52 $2,508 - $2,698
62 Added 1.01%
6,217 $265,000
Q2 2019

Jul 17, 2019

SELL
$39.4 - $42.7 $9,337 - $10,119
-237 Reduced 3.71%
6,155 $246,000
Q1 2019

Apr 11, 2019

SELL
$38.57 - $42.69 $25,957 - $28,730
-673 Reduced 9.53%
6,392 $267,000
Q4 2018

Jan 17, 2019

SELL
$37.8 - $42.69 $37,535 - $42,391
-993 Reduced 12.32%
7,065 $270,000
Q3 2018

Oct 15, 2018

SELL
$39.75 - $42.69 $7,751 - $8,324
-195 Reduced 2.36%
8,058 $324,000
Q2 2018

Jul 10, 2018

BUY
$39.61 - $42.76 $3,802 - $4,104
96 Added 1.18%
8,253 $333,000
Q1 2018

Apr 16, 2018

SELL
$36.18 - $40.15 $62,989 - $69,901
-1,741 Reduced 17.59%
8,157 $319,000
Q4 2017

Jan 17, 2018

SELL
$35.34 - $41.9 $23,854 - $28,282
-675 Reduced 6.38%
9,898 $351,000
Q3 2017

Oct 17, 2017

BUY
$39.44 - $41.55 $416,999 - $439,308
10,573
10,573 $429,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.